Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilberto Fisone

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Frontiers in Neuroanatomy|August 3, 2011
Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 SignalingAlessandra Bonito-Oliva, Michael Feyder, Gilberto Fisone
Neuropharmacology|April 18, 2012
mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neuronsMaria Teresa Dell'anno, Simone Pallottino, Gilberto Fisone
Frontiers in Behavioral Neuroscience|September 16, 2014
A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctionsAlessandra Bonito-Oliva, Débora Masini, Gilberto Fisone
Parkinson'S Disease|January 11, 2013
Dyskinesia in Parkinson's disease therapyAnna Rosa Carta, Andrea Giuffrida, Gilberto Fisone
Frontiers in Behavioral Neuroscience|October 27, 2011
L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated TransmissionMichael Feyder, Alessandra Bonito-Oliva, Gilberto Fisone
Physiology & Behavior|June 26, 2007
Signaling in the basal ganglia: postsynaptic and presynaptic mechanismsGilberto Fisone, Kerstin Håkansson, Anders Borgkvist, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 26, 2007
Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine rewardAnders Borgkvist, Alessandro Usiello, Paul Greengard, et al.
International Journal of Molecular Sciences|October 14, 2022
Haloperidol-Induced Immediate Early Genes in Striatopallidal Neurons Requires the Converging Action of cAMP/PKA/DARPP-32 and mTOR PathwaysOriane Onimus, Emmanuel Valjent, Gilberto Fisone, et al.
Frontiers in Neurology|April 25, 2018
Inhibition of mTORC1 Signaling Reverts Cognitive and Affective Deficits in a Mouse Model of Parkinson's DiseaseDébora Masini, Alessandra Bonito-Oliva, Maëlle Bertho, et al.
Neurobiology of Disease|June 8, 2013
Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1Elin K Allard, Mirjana Grujic, Gilberto Fisone, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Frontiers in Neuroanatomy|August 3, 2011
Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 SignalingAlessandra Bonito-Oliva, Michael Feyder, Gilberto Fisone
Neuropharmacology|April 18, 2012
mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neuronsMaria Teresa Dell'anno, Simone Pallottino, Gilberto Fisone
Frontiers in Behavioral Neuroscience|September 16, 2014
A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctionsAlessandra Bonito-Oliva, Débora Masini, Gilberto Fisone
Parkinson'S Disease|January 11, 2013
Dyskinesia in Parkinson's disease therapyAnna Rosa Carta, Andrea Giuffrida, Gilberto Fisone
Frontiers in Behavioral Neuroscience|October 27, 2011
L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated TransmissionMichael Feyder, Alessandra Bonito-Oliva, Gilberto Fisone
Physiology & Behavior|June 26, 2007
Signaling in the basal ganglia: postsynaptic and presynaptic mechanismsGilberto Fisone, Kerstin Håkansson, Anders Borgkvist, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 26, 2007
Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine rewardAnders Borgkvist, Alessandro Usiello, Paul Greengard, et al.
International Journal of Molecular Sciences|October 14, 2022
Haloperidol-Induced Immediate Early Genes in Striatopallidal Neurons Requires the Converging Action of cAMP/PKA/DARPP-32 and mTOR PathwaysOriane Onimus, Emmanuel Valjent, Gilberto Fisone, et al.
Frontiers in Neurology|April 25, 2018
Inhibition of mTORC1 Signaling Reverts Cognitive and Affective Deficits in a Mouse Model of Parkinson's DiseaseDébora Masini, Alessandra Bonito-Oliva, Maëlle Bertho, et al.
Neurobiology of Disease|June 8, 2013
Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1Elin K Allard, Mirjana Grujic, Gilberto Fisone, et al.
Pageof 10